Biosimilar: Difference between revisions
Created page with "{{Short description|Variant of a biopharmaceutical}} A '''biosimilar''' (also known as '''follow-on biologic''' or '''subsequent entry biologic''') is a biologic medical product that is almost an identical copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products and can be manufactured when the original product's patent expires. Referenc..." |
No edit summary |
||
| Line 1: | Line 1: | ||
<languages /> | |||
<translate> | |||
{{Short description|Variant of a biopharmaceutical}} | {{Short description|Variant of a biopharmaceutical}} | ||
A '''biosimilar''' (also known as '''follow-on biologic''' or '''subsequent entry biologic''') is a [[biopharmaceutical|biologic medical product]] that is almost an identical copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products and can be manufactured when the original product's [[chemical patent|patent]] expires. Reference to the innovator product is an integral component of the approval. | A '''biosimilar''' (also known as '''follow-on biologic''' or '''subsequent entry biologic''') is a [[biopharmaceutical|biologic medical product]] that is almost an identical copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products and can be manufactured when the original product's [[chemical patent|patent]] expires. Reference to the innovator product is an integral component of the approval. | ||
| Line 232: | Line 234: | ||
[[Category:Biopharmaceuticals]] | [[Category:Biopharmaceuticals]] | ||
[[Category:Life sciences industry]] | [[Category:Life sciences industry]] | ||
</translate> | |||